Finance

Beta
Lists
524494:BOM
IPCA Laboratories Ltd
₹1,554.50
+3.12%
(+47.00) 1D
Jun 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524494...
Open
₹1,509.00
High
₹1,561.60
Low
₹1,501.00
Mkt. cap
393.75B
Avg. vol.
23.15K
Volume
119.76K
Dividend
0.39%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
34.56
52-wk high
₹1,679.45
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
Open
₹1,509.00
High
₹1,561.60
Low
₹1,501.00
Mkt. cap
393.75B
Avg. vol.
23.15K
Volume
119.76K
Dividend
0.39%
Quarterly dividend
₹1.50
Ex-dividend date
Aug 7, 2026
P/E ratio
34.56
52-wk high
₹1,679.45
52-wk low
₹1,252.95
EPS
₹44.98
Shares outstanding
126.35M
No. of employees
17K
News stories
From sources across the web
Profile
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
About IPCA Laboratories Ltd
CEO-
Employees16.8K
FoundedOct 19, 1949
Headquarters-
SectorPharmaceutical industry
Websiteipca.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
23.09B
25.56B
23.92B
24.82B
Cost of goods sold
6.92B
7.82B
6.58B
6.92B
Cost of revenue
6.92B
7.82B
6.58B
6.92B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.43B
5.38B
5.46B
5.33B
Operating expense
13.01B
13.33B
13.09B
13.20B
Total operating expenses
19.92B
21.15B
19.67B
20.12B
Operating income
3.16B
4.42B
4.26B
4.70B
Other non operating income
326.60M
278.60M
201.90M
-
EBT including unusual items
3.29B
3.89B
4.46B
4.02B
EBT excluding unusual items
3.29B
4.47B
4.28B
4.48B
Income tax expense
960.90M
1.08B
819.30M
950.50M
Effective tax rate
29.21%
27.81%
18.39%
23.66%
Other operating expenses
6.58B
6.92B
6.55B
6.80B
Net income
2.33B
2.83B
3.26B
2.99B
Net profit margin
10.10%
11.05%
13.64%
12.05%
Earnings per share
9.19
12.35
12.09
13.31
Interest and investment income
-
-
-
-
Interest expense
-185.10M
-196.10M
-176.20M
-202.00M
Net interest expenses
-185.10M
-196.10M
-176.20M
-202.00M
Depreciation and amortization charges
1.00B
1.03B
1.08B
1.07B
EBITDA
4.09B
5.43B
5.18B
5.75B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer